BiomX gets NYSE American approval of compliance plan; deadline extended to Nov 2025

BiomX Inc.

NYSE American accepted BiomX's plan to regain compliance with continued listing standards under Sections 1003(a)(i), (ii), (iii).
Company has until November 23, 2025 to meet listing requirements; stock continues trading on NYSE American under PHGE.
Previously disclosed deficiency in May 2024; plan acceptance avoids immediate delisting but periodic reviews apply.
If compliance not achieved by Nov 2025 or insufficient progress, NYSE American may initiate delisting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.